Myogen, Inc.

Ambrisentan ARIES-2 data to be presented at Thoracic Society meeting

Published in Healthcare Mergers, Acquisitions and Ventures Week, April 8th, 2006

Myogen, Inc., (MYOG) announced that an abstract describing the effects of ambrisentan in patients with pulmonary arterial hypertension (PAH) has been selected for presentation at the annual International Conference of the American Thoracic Society to be held May 19-24, 2006 at the San Diego Convention Center in San Diego, California.

The abstract highlights efficacy and safety results from ARIES-2, the phase III trial of ambrisentan in 192 patients with PAH. The data demonstrate that ambrisentan improved exercise capacity, delayed clinical worsening and improved symptoms in patients with PAH. Ambrisentan was well tolerated and was not associated with any clinically...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2006-04-08)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

AAIPharma, Inc.
AAIPharma completes financial reorganization
Able Laboratories, Inc.
Able Laboratories files proposed plan of reorganization
Adeza
Adeza achieves 14th consecutive quarter of profitability
Adolor Corp.
Adolor reports loss of $1.45 per share
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences completes private placement for $36M
Aeterna Zentaris, Inc.
Aeterna Zentaris reports 65% increase in revenue
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry